5AM Ventures Leads Investment in eHealth Startup Pear Therapeutics
March 23, 2015
Pear Therapeutics, a developer of drug/software combination products that address a range of severe conditions, has received a new investment led by 5AM Ventures. Pear is developing digital health interventions to enhance the efficacy of pharmaceutical preparations. In conjunction with the deal, 5AM's founding managing partner Andrew Schwab has joined the company's Board of Directors.